Editorial.

Depression is one of midlife women's biggest concerns. That's why when I read Janet Currie's report on the Marketization of SSRIs, I knew I wanted to talk to her about her findings. The result is the Q&A cover feature this month. Janet is well-versed in this topic and I hope that you take away some valuable information to make the best decision for you and your mental health.

It's been two and a half years since I became the editor of A Friend Indeed. Over that time period, AFI has tackled many topics, from Endometriosis at Menopause (Nov/Dec 2003) to this month's feature on antidepressants. From the beginning of my tenure, I have tried to incorporate new ideas and explore novel areas of interest. Some of the new elements to the newsletter include columns on nutrition, fitness and alternative treatments. As a midlife woman myself, I have tried to get at the issues many of my friends, colleagues and conference-goers have asked me to explore. I hope I have provided enough information to answer many of your concerns.

So now, it is with regret that I announce that I will no longer be serving as editor. I have taken a fulltime position at another institution, which does not leave me time to devote my full attention to A Friend Indeed.

I wish you all a healthy menopause and midlife. Happy trails to you!

--June Rogers, Editor